Sort
326,823 grants matching “clinical trial”
DAIT CLINICAL SITE MONITORING CENTER
$2,198,272Mary Glessner · Ppd Development Lp · N01 · FY2022 · AI
Cancer Center Support Grant (CCSG)
$2,198,194George J Weiner · University Of Iowa · P30 · FY2006 · CA
Molecular Approaches To Antiviral Development For Viral Hepatitis and Other Viral Diseases
$2,198,134T. Jake Liang · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2023 · DK
Project 1 - Development of mRNA Immunogens for Protective Antibody Induction
$2,197,512Barton F Haynes · Duke University · U19 · FY2022 · AI
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH
$2,197,476Hugh Sampson · Icahn School Of Medicine At Mount Sinai · UL1 · FY2010 · RR
The University of Texas MD Anderson Cancer Center SPORE in Ovarian Cancer
$2,197,314Anil K Sood · University Of Tx Md Anderson Can Ctr · P50 · FY2024 · CA
Coordinating Center to Help Eliminate/Reduce Oral health Inequalities in Children
$2,197,111Stuart A Gansky · University Of California, San Francisco · U01 · FY2017 · DE
Hepatobiology and Toxicology COBRE
$2,197,056Craig J McClain · University Of Louisville · P20 · FY2025 · GM
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS
$2,197,014Etta D Pisano · Univ Of North Carolina Chapel Hill · UL1 · FY2009 · RR
SPORE: Dana-Farber/Harvard Cancer Center SPORE in Breast Cancer
$2,197,001Eric P Winer · Dana-Farber Cancer Inst · P50 · FY2014 · CA
Preclinical Consortium to Facilitate Translation of Cardioprotective Therapies
$2,197,000Roberto Bolli · University Of Louisville · U24 · FY2014 · HL
Preclinical Consortium to Facilitate Translation of Cardioprotective Therapies
$2,197,000Roberto Bolli · University Of Louisville · U24 · FY2011 · HL
Preclinical Consortium to Facilitate Translation of Cardioprotective Therapies
$2,197,000Roberto Bolli · University Of Louisville · U24 · FY2013 · HL
Preclinical Consortium to Facilitate Translation of Cardioprotective Therapies
$2,197,000Roberto Bolli · University Of Louisville · U24 · FY2012 · HL
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH
$2,196,647Steven M. Dubinett · University Of California Los Angeles · UL1 · FY2011 · RR
Systems Genetics of Tuberculosis
$2,196,559Christopher M Sassetti · Univ Of Massachusetts Med Sch Worcester · P01 · FY2020 · AI
Integrative Pathophysiology of Solid Tumors
$2,196,096Rakesh K. Jain · Massachusetts General Hospital · P01 · FY2014 · CA
Elafin Therapy for Lung Diseases
$2,196,011Marlene Rabinovitch · Stanford University · P01 · FY2015 · HL
Phase 1 and Phase 2 Clinical Trials of Agents for Cancer Prevention
$2,196,000Paul J Limburg · Mayo Clinic Rochester · N01 · FY2011 · CA
Coordinating Center to Help Eliminate/Reduce Oral health Inequalities in Children
$2,195,948Stuart A Gansky · University Of California, San Francisco · U01 · FY2018 · DE
MICHIGAN CANCER RESEARCH CONSORTIUM
$2,195,873Philip J Stella · Saint Joseph Mercy Health System · UG1 · FY2017 · CA
PLCO Trial Etiologic and Early Marker Study
$2,195,827Robert Hoover · Division Of Cancer Epidemiology And Genetics · ZIA · FY2014 · CA
UCSF PROSTATE CANCER SPORE
$2,195,771University Of California San Francisco · P50 · FY2002 · CA
An Alzheimer's Blood Test for Primary Care
$2,195,743Sid E O'Bryant · University Of North Texas Hlth Sci Ctr · R01 · FY2018 · AG
Immune Basis & Clinical implications of Threshold-Based Phenotypes of Peanut Allergy
$2,195,573Maria Cecilia Berin · Icahn School Of Medicine At Mount Sinai · U19 · FY2020 · AI